Trodelvy from Immunomedics gets US FDA orphan drug designation for glioblastoma EP News Bureau Oct 12, 2020 Trodelvy has shown encouraging activity in an early-stage study in brain cancers, including partial responses in small cohorts of…
Trodelvy from Immunomedics extends survival in breast cancer patients Reuters Sep 19, 2020 The FDA granted the drug accelerated approval for its use in metastatic triple-negative breast cancer (mTNBC) patients who had…
Gilead may soon buy Immunomedics in deal over $20 billion Reuters Sep 13, 2020 The deal, which will expand Gilead’s oncology portfolio, might get announced tomorrow if not sooner, inform reports
FDA approves new therapy for triple negative breast cancer that has spread, not responded to other… EP News Bureau Apr 23, 2020 The FDA granted approval of Trodelvy to Immunomedics